Phenoperidine

This classification denotes an opioid and analgesic agent with the molecular formula C23H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G9BH09J4JW, chemically known as 4-piperidinecarboxylic acid, 1-(3-hydroxy-3-phenylpropyl)-4-phenyl-, ethyl ester but generally known as phenoperidine, which bears US NIH Compound Identifier 11226. European Medicines Agency schedules Phenoperidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09775MIG. The term PHENOPERIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules phenoperidine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENOPERIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenoperidine under HS 29333300 and SITC 51574. As of Q4 2014, PHENOPERIDINE remains the US FDA Preferred Term for this commodity. Phenoperidine bears US NLM identifiers UMLS ID C0031432 and NCI Concept Code C72123. SMILES: O(C(=O)C1(CCN(CC1)CCC(O)C1CCCCC1)C1CCCCC1)CC.